IGM Biosciences, Inc. - stock earnings
IGMS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -60.7 million USD | 651000 USD |
| 2023Q3 | -62.0 million USD | 509000 USD |
| 2023Q2 | -64.4 million USD | 448000 USD |
| 2023Q1 | -59.3 million USD | 522000 USD |
| 2022Q4 | -48.2 million USD | 372000 USD |
| 2022Q3 | -55.6 million USD | 331000 USD |
| 2022Q2 | -58.0 million USD | 366000 USD |
| 2022Q1 | -51.8 million USD | ? USD |
| 2021Q4 | -50.6 million USD | ? USD |
| 2021Q3 | -44.2 million USD | ? USD |
| 2021Q2 | -38.7 million USD | ? USD |
| 2021Q1 | -31.6 million USD | ? USD |
| 2020Q4 | -24.6 million USD | ? USD |
| 2020Q3 | -20.3 million USD | ? USD |
| 2020Q2 | -18.8 million USD | ? USD |
| 2020Q1 | -17.6 million USD | ? USD |
| 2019Q4 | -14.8 million USD | ? USD |
| 2019Q3 | -10.2 million USD | ? USD |
| 2019Q2 | -10.7 million USD | ? USD |
| 2019Q1 | -7.5 million USD | ? USD |
| 2018Q4 | -9.1 million USD | ? USD |
| 2018Q3 | -6.5 million USD | ? USD |
| 2018Q2 | -3.6 million USD | ? USD |
| 2018Q1 | -3.6 million USD | ? USD |
IGMS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -246.4 million USD | 2.1 million USD |
| 2022 | -214.2 million USD | 1.1 million USD |
| 2021 | -160.7 million USD | 366000 USD |
| 2020 | -80.3 million USD | ? USD |
| 2019 | -42.5 million USD | ? USD |
| 2018 | -22.7 million USD | ? USD |
| 2017 | -11.1 million USD | ? USD |
IGMS
Price: $9.43
52 week price:
Earnings Per Share: -4.71 USD
P/E Ratio: -2.96
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 224815
Market Capitalization: 515.0 million